Latest News and Articles

• FDA Approves Rituxan Hycela for Blood Cancers
• Focusing on the Needs of AYA Patients With Lymphoma
• Agent Shows Impressive Results for Diffuse Large ..
• Expert Discusses Immunotherapy’s Promise in ..
• Combination Is Promising and Tolerable for MCL
• Expert Discusses the Changing Landscape of Mantle ..
• Agent Granted Priority Review to Treat Non-Hodgki ..
• Stem Cell Transplant Benefit Limited for Some Pat ..
• Copanlisib Granted Priority Review for Lymphoma
• New Rituxan Results as FDA Decision Nears for Lym ..